It is currently Fri Oct 21, 2016 4:39 pm

News News of Tysabri (Antegren or Natalizumab)

Site map of Tysabri (Antegren or Natalizumab) » Forum : Tysabri (Antegren or Natalizumab)

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Appointment for First Infusion?

Has anyone set up their appointment for the first Tysabri infusion yet?
Read more : Appointment for First Infusion? | Views : 8419 | Replies : 35

Tysabri in Europe

TYSABRI(R) Receives Approval in European Union for the Treatment of Relapsing Remitting Forms of Multiple Sclerosis

Biogen Idec and Elan Corporation, plc today announced that they received approval from the European Commission to market TYSABRI(R) (natalizumab) as a treatment for relapsing remitting multiple sclerosis (MS) to delay the progression of disability and reduce the frequency of relapses. TYSABRI is indicated as a single disease modifying therapy in highly active relapsing remitting MS for patients with ...
Read more : Tysabri in Europe | Views : 1622 | Replies : 0

infusion centers?

Has anyone come across where the infusion centers will be located in the US?
Read more : infusion centers? | Views : 5465 | Replies : 16

Tysabri Free Webcast Hosts Free Patient Webcast on Multiple Sclerosis and the FDA's Reapproval of Tysabri June 22nd, 8:30 PM (Eastern)

Program to Feature Prominent MS Experts Discussing the Drug and What It Means for Consumers

SEATTLE, June 15 /PRNewswire/ --

WHAT: HealthTalk Inc., a pioneer in patient education delivering live
and web-based programs on the latest treatments and research
news, is hosting a live webcast for Multiple Sclerosis
patients, their families and caregivers. Experts will be ...
Read more : Tysabri Free Webcast | Views : 1686 | Replies : 0

Tysabri Q&As

Read more : Tysabri Q&As | Views : 2172 | Replies : 0

It's BACK!!!!!!!!

US OKs resumed sales of Biogen and Elan's Tysabri

WASHINGTON (Reuters) - Biogen Idec Inc. and Elan Corp. won permission on Monday to resume sales of their multiple sclerosis drug Tysabri, which was withdrawn last year after it was linked to a rare but potentially fatal brain disease, U.S. regulators said.

The U.S. Food and Drug Administration said Tysabri must be sold under a restricted distribution plan to minimize chances of harm. Tysabri should be ...
Read more : It's BACK!!!!!!!! | Views : 2226 | Replies : 6

Tysabri back soon

The Sunday Times says that Tysabri might get FDA approval this week.

Sorry to spoil you Sunday lunch HarryZ :lol: Perhaps you could turn your attention to Rituxan or Dacluzimab.

The article says that Tysabri will be $23,000 a year. About as much as Harry takes each month from the dividends from his Biogen shares. :lol:


Read more : Tysabri back soon | Views : 1693 | Replies : 1


One for you HarryZ - UK MS Society presentation on Tysabri

Read more : Presentation | Views : 2001 | Replies : 3


Login  •  Register


Total posts 234569 • Total topics 25247 • Total members 16453

Contact us | Terms of Service